Targeted resequencing of the Myc locus in a subset of EP KPC tumours (three treated with vehicle and three treated with RMC-7977) provided orthogonal validation of the presence of Myc copy number gains in RMC-7977-treated EP tumours (Extended Data Fig. 6b). The gene discussed is MYC; the disease is neoplasm.